For the quarter ending 2026-03-31, CRBD made $3,964M in revenue. -$53M in net income. Net profit margin of -1.34%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenues | 3,964 | 6,731 | 5,416 | 2,744 |
| Policyholder benefits (includes remeasurement losses of 77 and 146 for the three months ended march 31, 2026 and 2025, respectively) | 974 | 3,140 | 2,594 | 982 |
| Change in the fair value of market risk benefits, net | -378 | -79 | -299 | 279 |
| Interest credited to policyholder account balances | 1,525 | 1,536 | 1,494 | 1,486 |
| Amortization of deferred policy acquisition costs and value of business acquired | 245 | 247 | 253 | 275 |
| Non-deferrable insurance commissions | 104 | 114 | 131 | 152 |
| Advisory fee expenses | 44 | 70 | 71 | 64 |
| General operating expenses | 468 | 442 | 481 | 535 |
| Interest expense | 131 | 132 | 135 | 137 |
| Net (gain) on divestitures | 2 | 0 | 0 | 0 |
| Total benefits and expenses | 3,867 | 5,760 | 5,458 | 3,352 |
| Income (gain) before income tax expense (benefit) | 97 | 971 | -42 | -608 |
| Current | - | 89* | - | - |
| Deferred | - | 84* | - | - |
| Income tax expense (benefit) | 158 | 173 | -179 | 60 |
| Net gain | -61 | 798 | 137 | -668 |
| Less net income (loss) attributable to noncontrolling interests | -8 | -16 | -7 | -8 |
| Net gain attributable to corebridge | -53 | 814 | 144 | -660 |
| Less preferred stock dividends | 0 | 0 | - | - |
| Net loss available to corebridge common shareholders | -53 | 814 | - | - |
| Basic EPS | -0.11 | 1.597 | 0.27 | -1.2 |
| Diluted EPS | -0.11 | 1.601 | 0.27 | -1.2 |
| Basic Average Shares | 473,500,000 | 509,800,000 | 539,100,000 | 550,300,000 |
| Diluted Average Shares | 473,500,000 | 508,300,000 | 540,600,000 | 550,300,000 |